Skip to main content
Equibles

Tidal Investments LLC

Position in SLS — SELLAS Life Sciences Group, Inc.

CIK 1600064 MILWAUKEE, WI
Back to SLS Full portfolio

Position in SLS

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$1,900,512
+$1,519,783 QoQ
Shares Held
128,761
+43.1% QoQ
Ownership
0.064%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#45
of 192 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in SLS Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Tidal Investments LLC holds $326,129,958 across 89 Biotechnology names. SLS ranks #42 (0.6% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 95,685 $47,529,610
2 REGN
Regeneron Pharmaceuticals, Inc.
 43,896 $27,370,911
3 RVMD
Revolution Medicines, Inc.
 109,096 $20,431,498
4 EXEL
Exelixis, Inc.
 375,316 $20,420,943
5 HALO
Halozyme Therapeutics, Inc.
 190,305 $14,895,171
6 INCY
Incyte Corp
 102,834 $11,657,262
7 ALNY
Alnylam Pharmaceuticals, Inc.
 33,541 $10,096,847
8 COGT
Cogent Biosciences, Inc.
 241,565 $9,348,565

All Filings in SLS

Export CSV
2 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,900,512 128,761
2026-03-31 $380,729 90,007